Wuhan Medical Research Project (grant number: WZ14C02) and the Natural Science Foundation General Program, the Department of Science and Technology, Hubei Province (grant number: 2017CFC873).
第一作者机构:[1]Department of Tradition Chinese Medicine, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan 450060, Hubei, China.
通讯作者:
推荐引用方式(GB/T 7714):
Li Chan,Xie Png,Lv Kun,et al.METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway[J].Endocrine, Metabolic & Immune Disorders Drug Targets.2024,doi:10.2174/0118715303290063240530053252.
APA:
Li Chan,Xie Png,Lv Kun,Yang Qian&Mou Yanjie.(2024).METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.Endocrine, Metabolic & Immune Disorders Drug Targets,,
MLA:
Li Chan,et al."METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway".Endocrine, Metabolic & Immune Disorders Drug Targets .(2024)